199 related articles for article (PubMed ID: 11245329)
21. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women.
Martínez MA; Ovalle A; Santa-Cruz A; Barrera B; Vidal R; Aguirre R
Scand J Infect Dis; 2001; 33(8):604-10. PubMed ID: 11525356
[TBL] [Abstract][Full Text] [Related]
22. The joint effect of vaginal Ureaplasma urealyticum and bacterial vaginosis on adverse pregnancy outcomes.
Vogel I; Thorsen P; Hogan VK; Schieve LA; Jacobsson B; Ferre CD
Acta Obstet Gynecol Scand; 2006; 85(7):778-85. PubMed ID: 16817073
[TBL] [Abstract][Full Text] [Related]
23. Prenatal microbiological risk factors associated with preterm birth.
McDonald HM; O'Loughlin JA; Jolley P; Vigneswaran R; McDonald PJ
Br J Obstet Gynaecol; 1992 Mar; 99(3):190-6. PubMed ID: 1606115
[TBL] [Abstract][Full Text] [Related]
24. First Trimester Vaginal Ureaplasma Biovar Colonization and Preterm Birth: Results of a Prospective Multicenter Study.
Rittenschober-Böhm J; Waldhoer T; Schulz SM; Stihsen B; Pimpel B; Goeral K; Hafner E; Sliutz G; Kasper DC; Witt A; Berger A
Neonatology; 2018; 113(1):1-6. PubMed ID: 28934751
[TBL] [Abstract][Full Text] [Related]
25. Cervical Ureaplasma urealyticum colonization might be associated with increased incidence of preterm delivery in pregnant women without prophlogistic microorganisms on routine examination.
Mitsunari M; Yoshida S; Deura I; Horie S; Tsukihara S; Harada T; Irie T; Terakawa N
J Obstet Gynaecol Res; 2005 Feb; 31(1):16-21. PubMed ID: 15669986
[TBL] [Abstract][Full Text] [Related]
26. Association of Ureaplasma urealyticum biovars with clinical outcome for neonates, obstetric patients, and gynecological patients with pelvic inflammatory disease.
Abele-Horn M; Wolff C; Dressel P; Pfaff F; Zimmermann A
J Clin Microbiol; 1997 May; 35(5):1199-202. PubMed ID: 9114407
[TBL] [Abstract][Full Text] [Related]
27. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes.
Kwak DW; Hwang HS; Kwon JY; Park YW; Kim YH
J Matern Fetal Neonatal Med; 2014 Mar; 27(4):333-7. PubMed ID: 23796000
[TBL] [Abstract][Full Text] [Related]
28. Detection of Ureaplasma urealyticum and Ureaplasma parvum in amniotic fluid: association with pregnancy outcomes.
Rodríguez N; Fernandez C; Zamora Y; Berdasquera D; Rivera JA
J Matern Fetal Neonatal Med; 2011 Jan; 24(1):47-50. PubMed ID: 20504068
[TBL] [Abstract][Full Text] [Related]
29. The Alabama Preterm Birth Study: umbilical cord blood Ureaplasma urealyticum and Mycoplasma hominis cultures in very preterm newborn infants.
Goldenberg RL; Andrews WW; Goepfert AR; Faye-Petersen O; Cliver SP; Carlo WA; Hauth JC
Am J Obstet Gynecol; 2008 Jan; 198(1):43.e1-5. PubMed ID: 18166302
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic treatment of intra-amniotic infection with Ureaplasma urealyticum. A case report and literature review.
Smorgick N; Frenkel E; Zaidenstein R; Lazarovitch T; Sherman DJ
Fetal Diagn Ther; 2007; 22(2):90-3. PubMed ID: 17135751
[TBL] [Abstract][Full Text] [Related]
31. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes.
Capoccia R; Greub G; Baud D
Curr Opin Infect Dis; 2013 Jun; 26(3):231-40. PubMed ID: 23587772
[TBL] [Abstract][Full Text] [Related]
32. Expectant management of premature rupture of membranes with amniotic fluid cultures positive for Ureaplasma urealyticum alone.
Gauthier DW; Meyer WJ; Bieniarz A
Am J Obstet Gynecol; 1994 Feb; 170(2):587-90. PubMed ID: 8116718
[TBL] [Abstract][Full Text] [Related]
33. Microbial and vaginal determinants influencing Mycoplasma hominis and Ureaplasma urealyticum genital colonization in a population of female patients.
Leli C; Meucci M; Vento S; D'Alò F; Farinelli S; Perito S; Bistoni F; Mencacci A
Infez Med; 2013 Sep; 21(3):201-6. PubMed ID: 24008852
[TBL] [Abstract][Full Text] [Related]
34. Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. The Vaginal Infections and Prematurity Study Group.
Carey JC; Blackwelder WC; Nugent RP; Matteson MA; Rao AV; Eschenbach DA; Lee ML; Rettig PJ; Regan JA; Geromanos KL
Am J Obstet Gynecol; 1991 Mar; 164(3):728-33. PubMed ID: 2003532
[TBL] [Abstract][Full Text] [Related]
35. Prolonged progesterone administration is associated with less frequent cervicovaginal colonization by Ureaplasma urealyticum during pregnancy - Results of a pilot study.
Koucký M; Malíčková K; Cindrová-Davies T; Smíšek J; Vráblíková H; Černý A; Šimják P; Slováčková M; Pařízek A; Zima T
J Reprod Immunol; 2016 Aug; 116():35-41. PubMed ID: 27172838
[TBL] [Abstract][Full Text] [Related]
36. Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants.
Kirchner L; Helmer H; Heinze G; Wald M; Brunbauer M; Weninger M; Zaknun D
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):44-50. PubMed ID: 17095137
[TBL] [Abstract][Full Text] [Related]
37. [Frequency of isolation of Ureaplasma urealyticum in an open population from southern Mexico City].
González Pedraza A; Catalina Ortiz-Zaragoza MA; Inzunza-Montiel AE; Ponce-Rosas ER
Rev Latinoam Microbiol; 1995; 37(2):79-86. PubMed ID: 8552879
[TBL] [Abstract][Full Text] [Related]
38. Association of Mycoplasma hominis and Ureaplasma urealyticum with some indicators of nonspecific vaginitis.
Cedillo-Ramírez L; Gil C; Zago I; Yáñez A; Giono S
Rev Latinoam Microbiol; 2000; 42(1):1-6. PubMed ID: 10948822
[TBL] [Abstract][Full Text] [Related]
39. Possible role of Ureaplasma urealyticum in preterm premature rupture of the fetal membranes.
Gravett MG; Eschenbach DA
Pediatr Infect Dis; 1986; 5(6 Suppl):S253-7. PubMed ID: 3540897
[TBL] [Abstract][Full Text] [Related]
40. Maternal genital colonization with Ureaplasma urealyticum promotes preterm delivery: association of the respiratory colonization of premature infants with chronic lung disease and increased mortality.
Kafetzis DA; Skevaki CL; Skouteri V; Gavrili S; Peppa K; Kostalos C; Petrochilou V; Michalas S
Clin Infect Dis; 2004 Oct; 39(8):1113-22. PubMed ID: 15486833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
